Nathalie Esser Selected Research

Nathalie Esser Research Topics

17	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2013
8	Obesity 10/2023 - 11/2013
7	Insulin Resistance 10/2023 - 11/2014
4	Inflammation (Inflammations) 01/2024 - 03/2015
4	Heart Failure 01/2022 - 01/2019
2	Amyloid Plaque 10/2022 - 12/2019
2	Body Weight (Weight, Body) 01/2022 - 12/2019
1	Glucose Intolerance 01/2024
1	Hyperglycemia 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	COVID-19 10/2020
1	Diabetes Complications 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2015
1	Infections 11/2014
1	Gouty Arthritis 11/2013
1	Atherosclerosis 11/2013
1	Osteoarthritis 01/2013

9	Neprilysin (Neutral Endopeptidase)IBA 10/2023 - 01/2018
8	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 03/2015
5	Amyloid (Amyloid Fibrils)IBA 01/2024 - 12/2019
5	Islet Amyloid PolypeptideIBA 01/2024 - 12/2019
5	Insulin (Novolin)FDA Link 01/2022 - 03/2015
5	InflammasomesIBA 01/2019 - 11/2013
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2018
3	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 08/2021
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 01/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 11/2014 - 11/2013
1	Caspase 3 (Caspase-3)IBA 01/2024
1	Peptides (Polypeptides)IBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 01/2022
1	Glucagon (Glukagon)FDA Link 09/2021
1	empagliflozinIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	SodiumIBA 01/2021
1	SymportersIBA 01/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 12/2019
1	perlecanIBA 12/2019
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 12/2019
1	GlycosaminoglycansIBA 12/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2014
1	InterleukinsIBA 11/2013
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2013

2	Therapeutics 01/2024 - 08/2014
2	Glycemic Control 01/2022 - 08/2021